Cargando…

Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target

Cytochrome P450 monooxygenases (CYPs/P450s) are heme-thiolate proteins whose role as a drug target against pathogenic microbes has been explored because of their stereo- and regio-specific oxidation activity. We aimed to assess the CYP53 family's role as a common alternative drug target against...

Descripción completa

Detalles Bibliográficos
Autores principales: Jawallapersand, Poojah, Mashele, Samson Sitheni, Kovačič, Lidija, Stojan, Jure, Komel, Radovan, Pakala, Suresh Babu, Kraševec, Nada, Syed, Khajamohiddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164535/
https://www.ncbi.nlm.nih.gov/pubmed/25222113
http://dx.doi.org/10.1371/journal.pone.0107209
_version_ 1782334968738873344
author Jawallapersand, Poojah
Mashele, Samson Sitheni
Kovačič, Lidija
Stojan, Jure
Komel, Radovan
Pakala, Suresh Babu
Kraševec, Nada
Syed, Khajamohiddin
author_facet Jawallapersand, Poojah
Mashele, Samson Sitheni
Kovačič, Lidija
Stojan, Jure
Komel, Radovan
Pakala, Suresh Babu
Kraševec, Nada
Syed, Khajamohiddin
author_sort Jawallapersand, Poojah
collection PubMed
description Cytochrome P450 monooxygenases (CYPs/P450s) are heme-thiolate proteins whose role as a drug target against pathogenic microbes has been explored because of their stereo- and regio-specific oxidation activity. We aimed to assess the CYP53 family's role as a common alternative drug target against animal (including human) and plant pathogenic fungi and its role in fungal-mediated wood degradation. Genome-wide analysis of fungal species revealed the presence of CYP53 members in ascomycetes and basidiomycetes. Basidiomycetes had a higher number of CYP53 members in their genomes than ascomycetes. Only two CYP53 subfamilies were found in ascomycetes and six subfamilies in basidiomycetes, suggesting that during the divergence of phyla ascomycetes lost CYP53 P450s. According to phylogenetic and gene-structure analysis, enrichment of CYP53 P450s in basidiomycetes occurred due to the extensive duplication of CYP53 P450s in their genomes. Numerous amino acids (103) were found to be conserved in the ascomycetes CYP53 P450s, against only seven in basidiomycetes CYP53 P450s. 3D-modelling and active-site cavity mapping data revealed that the ascomycetes CYP53 P450s have a highly conserved protein structure whereby 78% amino acids in the active-site cavity were found to be conserved. Because of this rigid nature of ascomycetes CYP53 P450s' active site cavity, any inhibitor directed against this P450 family can serve as a common anti-fungal drug target, particularly toward pathogenic ascomycetes. The dynamic nature of basidiomycetes CYP53 P450s at a gene and protein level indicates that these P450s are destined to acquire novel functions. Functional analysis of CYP53 P450s strongly supported our hypothesis that the ascomycetes CYP53 P450s ability is limited for detoxification of toxic molecules, whereas basidiomycetes CYP53 P450s play an additional role, i.e. involvement in degradation of wood and its derived components. This study is the first report on genome-wide comparative structural (gene and protein structure-level) and evolutionary analysis of a fungal P450 family.
format Online
Article
Text
id pubmed-4164535
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41645352014-09-19 Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target Jawallapersand, Poojah Mashele, Samson Sitheni Kovačič, Lidija Stojan, Jure Komel, Radovan Pakala, Suresh Babu Kraševec, Nada Syed, Khajamohiddin PLoS One Research Article Cytochrome P450 monooxygenases (CYPs/P450s) are heme-thiolate proteins whose role as a drug target against pathogenic microbes has been explored because of their stereo- and regio-specific oxidation activity. We aimed to assess the CYP53 family's role as a common alternative drug target against animal (including human) and plant pathogenic fungi and its role in fungal-mediated wood degradation. Genome-wide analysis of fungal species revealed the presence of CYP53 members in ascomycetes and basidiomycetes. Basidiomycetes had a higher number of CYP53 members in their genomes than ascomycetes. Only two CYP53 subfamilies were found in ascomycetes and six subfamilies in basidiomycetes, suggesting that during the divergence of phyla ascomycetes lost CYP53 P450s. According to phylogenetic and gene-structure analysis, enrichment of CYP53 P450s in basidiomycetes occurred due to the extensive duplication of CYP53 P450s in their genomes. Numerous amino acids (103) were found to be conserved in the ascomycetes CYP53 P450s, against only seven in basidiomycetes CYP53 P450s. 3D-modelling and active-site cavity mapping data revealed that the ascomycetes CYP53 P450s have a highly conserved protein structure whereby 78% amino acids in the active-site cavity were found to be conserved. Because of this rigid nature of ascomycetes CYP53 P450s' active site cavity, any inhibitor directed against this P450 family can serve as a common anti-fungal drug target, particularly toward pathogenic ascomycetes. The dynamic nature of basidiomycetes CYP53 P450s at a gene and protein level indicates that these P450s are destined to acquire novel functions. Functional analysis of CYP53 P450s strongly supported our hypothesis that the ascomycetes CYP53 P450s ability is limited for detoxification of toxic molecules, whereas basidiomycetes CYP53 P450s play an additional role, i.e. involvement in degradation of wood and its derived components. This study is the first report on genome-wide comparative structural (gene and protein structure-level) and evolutionary analysis of a fungal P450 family. Public Library of Science 2014-09-15 /pmc/articles/PMC4164535/ /pubmed/25222113 http://dx.doi.org/10.1371/journal.pone.0107209 Text en © 2014 Jawallapersand et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Jawallapersand, Poojah
Mashele, Samson Sitheni
Kovačič, Lidija
Stojan, Jure
Komel, Radovan
Pakala, Suresh Babu
Kraševec, Nada
Syed, Khajamohiddin
Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target
title Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target
title_full Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target
title_fullStr Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target
title_full_unstemmed Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target
title_short Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target
title_sort cytochrome p450 monooxygenase cyp53 family in fungi: comparative structural and evolutionary analysis and its role as a common alternative anti-fungal drug target
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164535/
https://www.ncbi.nlm.nih.gov/pubmed/25222113
http://dx.doi.org/10.1371/journal.pone.0107209
work_keys_str_mv AT jawallapersandpoojah cytochromep450monooxygenasecyp53familyinfungicomparativestructuralandevolutionaryanalysisanditsroleasacommonalternativeantifungaldrugtarget
AT mashelesamsonsitheni cytochromep450monooxygenasecyp53familyinfungicomparativestructuralandevolutionaryanalysisanditsroleasacommonalternativeantifungaldrugtarget
AT kovaciclidija cytochromep450monooxygenasecyp53familyinfungicomparativestructuralandevolutionaryanalysisanditsroleasacommonalternativeantifungaldrugtarget
AT stojanjure cytochromep450monooxygenasecyp53familyinfungicomparativestructuralandevolutionaryanalysisanditsroleasacommonalternativeantifungaldrugtarget
AT komelradovan cytochromep450monooxygenasecyp53familyinfungicomparativestructuralandevolutionaryanalysisanditsroleasacommonalternativeantifungaldrugtarget
AT pakalasureshbabu cytochromep450monooxygenasecyp53familyinfungicomparativestructuralandevolutionaryanalysisanditsroleasacommonalternativeantifungaldrugtarget
AT krasevecnada cytochromep450monooxygenasecyp53familyinfungicomparativestructuralandevolutionaryanalysisanditsroleasacommonalternativeantifungaldrugtarget
AT syedkhajamohiddin cytochromep450monooxygenasecyp53familyinfungicomparativestructuralandevolutionaryanalysisanditsroleasacommonalternativeantifungaldrugtarget